Literature DB >> 2999237

TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.

M Okada, M Maeda, Y Tagaya, Y Taniguchi, K Teshigawara, T Yoshiki, T Diamantstein, K A Smith, T Uchiyama, T Honjo.   

Abstract

Interleukin 2 (IL 2) receptor (IL 2-R) is constitutively expressed on T cell lines established from the patients with adult T cell leukemia (ATL), which is a human T cell leukemia lymphoma virus (HTLV-1)(+) T4(+)-leukemia endemic in Japan, the United States, and other countries. Many of these cell lines continuously produce an acidic lymphokine, ATL-derived factor (ADF), which preferentially induces the synthesis and expression of IL 2-R on a sensitive HTLV-1(-) non-T cell line (YT). The induced IL 2-R was characterized by the binding of 125I-IL 2 and flow cytometry by using fluoresceinated anti-human IL 2-R monoclonal antibodies (anti-Tac). Scatchard analysis with 125I-IL 2 showed ADF induced high-affinity receptor sites on YT cells. To test the possibility that ADF produced by HTLV-1(+) T cells is involved in the abnormal expression of IL 2-R, we studied the effect of ADF on an HTLV-1(+) IL 2-dependent T cell line (ED) in which the beta-chain gene of the T cell antigen receptor (T beta) was rearranged. Unlike IL 2-independent HTLV-1(+) cell lines that constitutively expressed Il 2-R, the IL 2-R expression on ED cells declined in the absence of crude IL 2 or recombinant IL 2. When either ADF or recombinant IL 2 was added to the culture of ED cells, there was a dose-dependent enhancement of IL 2-R expression in 24 hr. ADF and IL 2 showed a synergism in the IL 2-R induction, and both factors were needed to induce the maximal receptor expression in these T cells. The lack of IL 2 production by ADF-treated YT, as well as ED cell line suggested IL 2 may not be involved in the IL 2-R induction by ADF. Northern blot hybridization with human IL 2-R cDNA probe showed the increase of IL 2-R mRNA in YT cells after ADF-treatment. ADF also enhanced IL 2-R expression of a rat T cell line transformed by HTLV-1(TARS-1), as demonstrated with anti-rat IL 2 receptor monoclonal antibodies (ART-18). An ADF-like IL 2-R-inducing factor was also detected in the conditioned medium of two HTLV-1(+) rat T cell lines (TARL-2 and TART-1), which constitutively expressed a higher number of Il 2-R than TARS-1 cells.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999237

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes.

Authors:  Y Nakamura; T Inamoto; K Sugie; H Masutani; T Shindo; Y Tagaya; A Yamauchi; K Ozawa; J Yodoi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Expression of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in the human ovary throughout the menstrual cycle.

Authors:  T Iwai; S Fujii; Y Nanbu; H Nonogaki; I Konishi; T Mori; H Masutani; J Yodoi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation.

Authors:  T Koura; Y Gon; S Hashimoto; A Azuma; S Kudoh; Y Fukuda; I Sugawara; J Yodoi; T Horie
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

4.  IL-1-induced production of IL-2 and IFN-gamma in subclones of human T-cell derived leukaemia HSB.2 cells: regulation by phytohaemagglutinin-mediated (poly)phosphoinositide breakdown and cyclic AMP.

Authors:  H Yagisawa; T Kasahara; N Mukaida; K Yamashita; K Shioiri-Nakano
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

5.  Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).

Authors:  T Shindo; K Sugie; K Nakamura; Y Tagaya; M Maeda; T Uchiyama; K Sagawa; M Yokoyama; H Wada; S Hitomi
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

6.  Characterization of a neu/c-erbB-2 protein-specific activating factor.

Authors:  K Dobashi; J G Davis; Y Mikami; J K Freeman; J Hamuro; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Expression of the adult T-cell leukemia-derived factor, human thioredoxin, in the allotransplanted canine lung.

Authors:  K Muro; T Go; T Hirata; T Fukuse; H Yokomise; K Inui; J Yodoi; S Hitomi; H Wada
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells.

Authors:  S Makino; H Masutani; N Maekawa; I Konishi; S Fujii; R Yamamoto; J Yodoi
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

9.  Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression.

Authors:  K L McGuire; V E Curtiss; E L Larson; W A Haseltine
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  High affinity interleukin 2 receptors in HTLV-1-infected T cells can mediate signals for gene expression.

Authors:  M Sakitani; M Nakamura; M Fujii; K Sugamura; Y Hinuma
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.